Becton, Dickinson and Co. | BDX - Assets


Becton, Dickinson and Co. reported $50.73B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.97B 902M Jun/2026
Align Technology USD 6.52B 103.03M Sep/2026
AngioDynamics USD 269.68M 4.04M Sep/2025
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
Danaher USD 93.28B 914M Sep/2026
Dentsply International USD 5.2B 25M Jun/2026
Dexcom USD 6.24B 216.5M Sep/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Solventum Corp USD 14.24B 146M Jun/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 6.79B 3.78M Jun/2026
Terumo JPY 2.37T 61.86B Jun/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026